These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10845393)

  • 1. Treatment of supratentorial glioblastoma multiforme with radiotherapy and a combination of BCNU and tamoxifen: a phase II study.
    Napolitano M; Keime-Guibert F; Monjour A; Lafitte C; Ameri A; Cornu P; Broët P; Delattre JY
    J Neurooncol; 1999; 45(3):229-35. PubMed ID: 10845393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extent of resection and Carmustine wafer implantation safely improve survival in patients with a newly diagnosed glioblastoma: a single center experience of the current practice.
    Roux A; Peeters S; Zanello M; Bou Nassif R; Abi Lahoud G; Dezamis E; Parraga E; Lechapt-Zalcmann E; Dhermain F; Dumont S; Louvel G; Chretien F; Sauvageon X; Devaux B; Oppenheim C; Pallud J
    J Neurooncol; 2017 Oct; 135(1):83-92. PubMed ID: 28669011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III trial of carmustine and cisplatin compared with carmustine alone and standard radiation therapy or accelerated radiation therapy in patients with glioblastoma multiforme: North Central Cancer Treatment Group 93-72-52 and Southwest Oncology Group 9503 Trials.
    Buckner JC; Ballman KV; Michalak JC; Burton GV; Cascino TL; Schomberg PJ; Hawkins RB; Scheithauer BW; Sandler HM; Marks RS; O'Fallon JR; ;
    J Clin Oncol; 2006 Aug; 24(24):3871-9. PubMed ID: 16921039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Final report of a phase I/II trial of hyperfractionated and accelerated hyperfractionated radiation therapy with carmustine for adults with supratentorial malignant gliomas. Radiation Therapy Oncology Group Study 83-02.
    Werner-Wasik M; Scott CB; Nelson DF; Gaspar LE; Murray KJ; Fischbach JA; Nelson JS; Weinstein AS; Curran WJ
    Cancer; 1996 Apr; 77(8):1535-43. PubMed ID: 8608540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients.
    Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO
    Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose BCNU with ABMT followed by radiation therapy in the treatment of supratentorial glioblastoma multiforme.
    Linassier C; Benboubker L; Velut S; Calais G; Saudeau D; Jan M; Autret A; Berger C; Biron P; Colombat P
    Bone Marrow Transplant; 1996 Sep; 18 Suppl 1():S69-72. PubMed ID: 8899180
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma--possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: report of the Radiation Therapy Oncology Group Protocol 8302.
    Nelson DF; Curran WJ; Scott C; Nelson JS; Weinstein AS; Ahmad K; Constine LS; Murray K; Powlis WD; Mohiuddin M
    Int J Radiat Oncol Biol Phys; 1993 Jan; 25(2):193-207. PubMed ID: 8380567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II study of continuous infusion carmustine and cisplatin followed by cranial irradiation in adults with newly diagnosed high-grade astrocytoma.
    Grossman SA; Wharam M; Sheidler V; Kleinberg L; Zeltzman M; Yue N; Piantadosi S
    J Clin Oncol; 1997 Jul; 15(7):2596-603. PubMed ID: 9215830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of stereotactic radiosurgery followed by conventional radiotherapy with carmustine to conventional radiotherapy with carmustine for patients with glioblastoma multiforme: report of Radiation Therapy Oncology Group 93-05 protocol.
    Souhami L; Seiferheld W; Brachman D; Podgorsak EB; Werner-Wasik M; Lustig R; Schultz CJ; Sause W; Okunieff P; Buckner J; Zamorano L; Mehta MP; Curran WJ
    Int J Radiat Oncol Biol Phys; 2004 Nov; 60(3):853-60. PubMed ID: 15465203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MGMT promoter methylation status and prognosis of patients with primary or recurrent glioblastoma treated with carmustine wafers.
    Gutenberg A; Bock HC; Brück W; Doerner L; Mehdorn HM; Roggendorf W; Westphal M; Felsberg J; Reifenberger G; Giese A
    Br J Neurosurg; 2013 Dec; 27(6):772-8. PubMed ID: 23662801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II radiation therapy oncology group trial of weekly paclitaxel and conventional external beam radiation therapy for supratentorial glioblastoma multiforme.
    Langer CJ; Ruffer J; Rhodes H; Paulus R; Murray K; Movsas B; Curran W
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):113-9. PubMed ID: 11516860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chemotherapy of recurrent supratentorial malignant gliomas (phase II study)].
    Afra D; Sipos L; Vitanovics D
    Ideggyogy Sz; 2002 Jan; 55(1-2):38-44. PubMed ID: 12122942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and feasibility of the adjunct of local chemotherapy with biodegradable carmustine (BCNU) wafers to the standard multimodal approach to high grade gliomas at first diagnosis.
    Salvati M; D'elia A; Frati A; Brogna C; Santoro A; Delfini R
    J Neurosurg Sci; 2011 Mar; 55(1):1-6. PubMed ID: 21464805
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394.
    Grossman SA; O'Neill A; Grunnet M; Mehta M; Pearlman JL; Wagner H; Gilbert M; Newton HB; Hellman R;
    J Clin Oncol; 2003 Apr; 21(8):1485-91. PubMed ID: 12697871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome in elderly patients undergoing definitive surgery and radiation therapy for supratentorial glioblastoma multiforme at a tertiary care institution.
    Mohan DS; Suh JH; Phan JL; Kupelian PA; Cohen BH; Barnett GH
    Int J Radiat Oncol Biol Phys; 1998 Dec; 42(5):981-7. PubMed ID: 9869219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I three-dimensional conformal radiation dose escalation study in newly diagnosed glioblastoma: Radiation Therapy Oncology Group Trial 98-03.
    Tsien C; Moughan J; Michalski JM; Gilbert MR; Purdy J; Simpson J; Kresel JJ; Curran WJ; Diaz A; Mehta MP;
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(3):699-708. PubMed ID: 18723297
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: phase I trial.
    Brem H; Ewend MG; Piantadosi S; Greenhoot J; Burger PC; Sisti M
    J Neurooncol; 1995 Nov; 26(2):111-23. PubMed ID: 8787853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase III randomized prospective trial of external beam radiotherapy, mitomycin C, carmustine, and 6-mercaptopurine for the treatment of adults with anaplastic glioma of the brain. CNS Cancer Consortium.
    Halperin EC; Herndon J; Schold SC; Brown M; Vick N; Cairncross JG; Macdonald DR; Gaspar L; Fischer B; Dropcho E; Rosenfeld S; Morowitz R; Piepmeier J; Hait W; Byrne T; Salter M; Imperato J; Khandekar J; Paleologos N; Burger P; Bentel GC; Friedman A
    Int J Radiat Oncol Biol Phys; 1996 Mar; 34(4):793-802. PubMed ID: 8598355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment results and outcome in elderly patients with glioblastoma multiforme--a retrospective single institution analysis.
    Hoffermann M; Bruckmann L; Kariem Mahdy A; Asslaber M; Payer F; von Campe G
    Clin Neurol Neurosurg; 2015 Jan; 128():60-9. PubMed ID: 25462098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does high-dose carmustine increase overall survival in supratentorial high-grade malignant glioma? An EBMT retrospective study.
    Bay JO; Linassier C; Biron P; Durando X; Verrelle P; Kwiatkowski F; Rosti G; Demirer T;
    Int J Cancer; 2007 Apr; 120(8):1782-6. PubMed ID: 17230505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.